Jessi L. Corcoran - 05 Jun 2026 Form 4 Insider Report for Medline Inc. (MDLN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Jun 2026, 16:30:09 UTC
Prior SEC filing
06 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nicole Fritz, Attorney-in-Fact

Key filing fact

Jessi L. Corcoran filed Form 4 for Medline Inc. (MDLN) on 09 Jun 2026.

Key facts

  • This page summarizes Jessi L. Corcoran's Form 4 filing for Medline Inc. (MDLN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Jun 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 06 Mar 2026.
  • Current net transaction value: +$170,750.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001750376 Primary reporting owner

CORCORAN JESSI L

Relationship
Principal Accounting Officer
Address
C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD
Signature
/s/ Nicole Fritz, Attorney-in-Fact
Signature date
09 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDLN transaction

Class A Common Stock

Purchase

Transaction value
$170,750
Shares
+5,000
Change %
Price
$34.15
Shares after
5,000
Date
05 Jun 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .